Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 123
Filter
1.
Anal Biochem ; 422(2): 74-8, 2012 Mar 15.
Article in English | MEDLINE | ID: mdl-22197418

ABSTRACT

DNA methylation, the conversion of cytosine to 5-methylcytosine, is an important epigenetic modification involved in gene regulation. DNA methylation is essential for normal development whereas abnormal methylation has been implicated in pathological conditions including cancer. To evaluate the extent and variation of genome-wide DNA methylation and its changes during cellular differentiation and tumorgenesis as well as the interplay with histone modifications, accurate and reproducible quantification of the genomic DNA methylation level is required. These measurements have so far been achieved only by sophisticated and costly techniques. Here we report the generation of an enzyme-linked immunosorbent assay (methDNA-ELISA) for the accurate quantification of global DNA methylation levels. The linear region of this methDNA-ELISA ranges from 1 to 10%, making it highly suitable for the typical ranges from 2 to 6% in mammalian genomes. This method requires 10 ng of isolated DNA per sample, thus permitting investigation with minimal amounts of DNA previously not applicable for global DNA methylation analysis, e.g., clinical biopsies or cells collected by microdissection.


Subject(s)
5-Methylcytosine/metabolism , DNA/analysis , Enzyme-Linked Immunosorbent Assay/methods , Cell Line, Tumor , Cost-Benefit Analysis , Cytosine/metabolism , DNA/genetics , DNA/metabolism , DNA Methylation/genetics , Enzyme-Linked Immunosorbent Assay/economics , Gene Expression Regulation , Genome, Human , Humans , Keratinocytes/cytology , Keratinocytes/metabolism , Spectrometry, Mass, Electrospray Ionization
2.
Int Immunopharmacol ; 11(11): 1789-95, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21820085

ABSTRACT

Unmethylated CpG-DNA motifs from pathogens are detected by the pattern recognition receptor toll-like receptor 9 (TLR9), eliciting an inflammatory immune response. These DNA sequences have been identified as potent immune modifiers and are used as adjuvants in vaccine research. Since we previously found TLR9 expression and function in human endothelial cells, we have here investigated whether endothelial cells play a role in the recognition of respective ligands and whether their response might contribute to vaccination success. We determined the effect of CpG-DNA on the inflammatory response of human endothelial cells of aortic or skin microvascular origin (HAoEC, HDMEC and HMEC-1) and compared the effects to those of two identically treated human macrophage cell lines. Using the same CpG-DNA D19(chimera) sequence in both cell types, we find the known up-regulation of pro-inflammatory cytokines in macrophages but consistent and significant inhibition of the pro-inflammatory response (IL-6, IL-8, and IFN-beta1) in endothelial cells. This inhibition is accompanied by enhanced proliferation and an increase in IL-10 gene expression. This anti-inflammatory response persists even in the presence of pro-inflammatory cytokines and low LPS concentrations, and is overruled only in the presence of relatively high concentrations of LPS. By testing different sequences, we find the strongest response with phosphorothioate bonds. Our results demonstrate an important regulatory function of endothelial cells in inflammatory responses, and the apparent Th2-like endothelial response in the human system may contribute significantly to the adjuvant activity of CpG-DNA.


Subject(s)
Adjuvants, Immunologic/pharmacology , CpG Islands , Endothelial Cells/drug effects , Macrophages/drug effects , Oligodeoxyribonucleotides/pharmacology , Th2 Cells/drug effects , Adjuvants, Immunologic/genetics , Cell Line, Tumor , Cell Survival/drug effects , CpG Islands/immunology , Endothelial Cells/immunology , Enzyme-Linked Immunosorbent Assay , Humans , Immunity, Innate/drug effects , Interferon-beta/antagonists & inhibitors , Interleukin-10/genetics , Interleukin-6/antagonists & inhibitors , Interleukin-8/antagonists & inhibitors , Ligands , Macrophages/immunology , Oligodeoxyribonucleotides/genetics , Real-Time Polymerase Chain Reaction , Th2 Cells/immunology , Toll-Like Receptor 9/immunology
3.
J Periodontal Res ; 42(4): 318-24, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17559628

ABSTRACT

BACKGROUND AND OBJECTIVE: Experimental gingivitis has been studied extensively as a well-controlled laboratory model of gingivitis. It is unclear, however, how experimental gingivitis compares with persistent plaque and gingivitis in more naturalistic settings. The present study compares both conditions in a randomized controlled design. MATERIAL AND METHODS: Twenty-six students suffering from plaque and gingivitis were randomly assigned to either a persistent gingivitis or an experimental gingivitis condition. Subjects with persistent gingivitis continued their habitual (i.e. insufficient) oral hygiene behaviour, resulting in persistence of plaque and gingivitis. Experimental gingivitis consisted of initial prophylaxis and subsequent total neglect of oral hygiene. Crevicular interleukin-1beta and interleukin-8 and clinical data were assessed weekly. RESULTS: After 4 wk, subjects with experimental gingivitis showed significantly more plaque accumulation (p = 0.005), higher interleukin-1beta (p = 0.037), and lower interleukin-8 (p = 0.043) concentrations than subjects with persistent gingivitis. Whereas in experimental gingivitis we observed considerable fluctuations in clinical and immunological parameters over the 4-wk period, persistent gingivitis was characterized by little fluctuation, indicating that we were monitoring an inflammatory steady state. CONCLUSION: The data indicate that conditions observed after 4 wk of experimental gingivitis are not comparable with persistent gingival inflammation in a naturalistic setting. Results are discussed with respect to current studies, indicating that chronic inflammation may reflect a stage of down-regulated pro-inflammatory response.


Subject(s)
Gingival Crevicular Fluid/immunology , Gingivitis/immunology , Interleukin-1beta/analysis , Interleukin-8/analysis , Adult , Dental Plaque/complications , Dental Plaque/therapy , Epidemiologic Methods , Female , Humans , Male , Oral Hygiene , Periodontal Index , Sex Factors
4.
Rheumatology (Oxford) ; 45 Suppl 3: iii14-6, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16987823

ABSTRACT

The pathophysiology of cutaneous lupus erythematosus (CLE) has been investigated in numerous studies demonstrating that the combination of specific cellular and molecular events is leading to inflammation and tissue damage in this disease. However, a complete understanding of the diverse pathophysiological mechanisms and interactions does not exist. Various environmental factors influence the clinical expression of CLE and a striking relationship has emerged between sunlight exposure and the various subtypes of this disease. In the past years, photoprovocation tests with different ultraviolet (UV) wavelengths have been approved to be an optimal way to evaluate photosensitivity in patients with CLE. Furthermore, research on the pathogenetic mechanisms of UV-induced skin lesions has become an increasingly dynamic field and several new aspects of this disease could be identified. In this review, the impact of UV exposure that contributes to the manifestations of CLE is discussed and recently reported mechanisms in the pathophysiology of this disease are considered including the clearance of apoptotic cells, expression of inducible nitric oxide synthase, function of CD4(+)CD25(+) regulatory T cells, and the role of chemokines for lymphocyte recruitment. Elucidation of the relevant factors might lead to future development of effective strategies to prevent abnormal reactivity in patients with CLE.


Subject(s)
Lupus Erythematosus, Cutaneous/etiology , Lupus Erythematosus, Cutaneous/pathology , Ultraviolet Rays/adverse effects , Apoptosis , Humans , Lupus Erythematosus, Cutaneous/immunology , Lupus Erythematosus, Cutaneous/metabolism , Nitric Oxide Synthase Type II/metabolism
5.
Rheumatology (Oxford) ; 45 Suppl 3: iii17-9, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16987824

ABSTRACT

When studying the impact of endothelins (ETs) on physiology and pathophysiology, this needs to be done in the context of nitric oxide (NO) synthesis and action, since these two are closely intertwined in their action. Here, we will review the work demonstrating the crosstalk between endothelin-1 (ET-1) and NO, and the recent developments regarding the role of these two mediators in inflammatory processes. Moreover, we will discuss the role of NO in pro-inflammatory diseases and the potential mechanisms of the anti-inflammatory activity of ET receptor antagonism.


Subject(s)
Endothelin-1/physiology , Inflammation/metabolism , Nitric Oxide/physiology , Endothelin Receptor Antagonists , Humans , Nitric Oxide Synthase/metabolism
6.
Pharmacopsychiatry ; 36(1): 37-41, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12649775

ABSTRACT

A 45-year-old female suffering from severe chronic schizophrenia of the paranoid type did not respond to typical antipsychotics. Five weeks after starting therapy with clozapine, she developed a clozapine-induced agranulocytosis (CA). Discontinuation of clozapine and treatment with granulocyte colony-stimulating factor (G-CSF) led to normalization of blood neutrophil counts within three weeks. This report suggests enhanced apoptosis of blood neutrophils during the acute phase of CA resulting from enhanced expression of the pro-apoptotic proteins Bax and Bik and from a decrease of the anti-apoptotic BCl-X(L) mRNA. The time course of decline and recovery of neutrophilic cells, as well as the release pattern of endogenous G-CSF, resembles those of chemotherapy-induced neutropenia. The kinetics of CD 34-positive cells mimics that of cytotoxic progenitor cell mobilization, e. g., after cytostatic drug administration. Our findings argue against the hypothesis that clozapine-mediated inhibition of G-CSF or granulocyte-macrophage colony-stimulating factor (GM-CSF) release is involved in CA development. Because clozapine-induced cell death mainly affects the neutrophil lineage, the elucidation of the exact mechanism of CA may open new perspectives for the treatment of psychiatric and possibly hematological disorders.


Subject(s)
Agranulocytosis/chemically induced , Antipsychotic Agents/adverse effects , Clozapine/adverse effects , Neutrophils/cytology , Schizophrenia, Paranoid/drug therapy , Apoptosis/drug effects , Female , Humans , Middle Aged , Neutrophils/drug effects
7.
J Invest Dermatol ; 117(5): 1200-5, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11710933

ABSTRACT

Skin exposure to ultraviolet radiation from sunlight causes erythema and edema formation as well as inflammatory responses. As some of these ultraviolet-induced effects are potentially mediated by nitric oxide synthases, we examined the role of cytokines and ultraviolet A1 radiation (340-400 nm) on the expression of the nitric oxide synthase-2 in endothelia of normal human skin biopsies during short-term organ culture as well as expression and activity of the nitric oxide synthase-2 in in vitro cell cultures of human dermal endothelial cells. Both, cytokine challenge (interleukin-1beta + tumor necrosis factor-alpha + interferon-gamma) but also ultraviolet A1 exposure (50 J per cm2) in the absence of cytokines led to the expression of nitric oxide synthase-2 in human skin organ cultures as shown by immunohistochemistry. Moreover, exposing human dermal endothelial cell cultures to proinflammatory cytokines but also to ultraviolet A1 radiation (6-24 J per cm2) in the absence of cytokines resulted in significant nitric oxide synthase-2 mRNA and protein expression as well as enzyme activity. Ultraviolet A1 irradiation of cytokine activated cells led to further increases in nitric oxide synthase-2 mRNA, protein expression, and enzyme activity. Moreover, a reporter gene assay using a human nitric oxide synthase-2 promoter construct provide evidence that ultraviolet A1, in the absence of cytokines, induces nitric oxide synthase-2 expression and activity, as previously shown for cytokines. Thus, the results presented here demonstrate for the first time that in dermal endothelia of human skin ultraviolet A1 radiation alone represents a proinflammatory stimulus sufficient to initiate nitric oxide synthase-2 expression as well as activity comparable with the respective response seen in the presence of proinflammatory cytokines.


Subject(s)
Nitric Oxide Synthase/metabolism , Skin/enzymology , Skin/radiation effects , Ultraviolet Rays , Cell Line , Cytokines/pharmacology , Endothelium/cytology , Endothelium/drug effects , Endothelium/enzymology , Endothelium/radiation effects , Enzyme Induction , Humans , Inflammation Mediators/pharmacology , Interferon-gamma/pharmacology , Interleukin-1/pharmacology , Nitric Oxide Synthase Type II , Promoter Regions, Genetic/physiology , Promoter Regions, Genetic/radiation effects , Skin/cytology , Skin/drug effects , Tumor Necrosis Factor-alpha/pharmacology
8.
Nitric Oxide ; 5(4): 289-95, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11485367

ABSTRACT

As a consequence of bacterial infection and the ensuing inflammation, expression of the inducible NO synthase results in prolonged synthesis of NO in high concentrations, which among other functions, contributes to the innate defense against the infectious agent. Here we show that NO inhibits the ability of the bacterial cochaperone DnaJ containing a RING finger-like domain to cooperate with the Hsp70 chaperone DnaK in mediating correct folding of denatured rhodanese. This inhibition is accompanied by S-nitrosation of DnaJ as well as by Zn2+ release from the protein. In contrast, NO has no effect on the activity of GroEL, a bacterial chaperone without zinc sulfur clusters. Escherichia coli cells lacking the chaperone trigger factor and thus relying on the DnaJ/DnaK system are more susceptible toward NO-mediated cytostasis than are wild-type bacteria. Our studies identify the cochaperone DnaJ as a molecular target for NO. Thus, an encounter of bacterial cells with NO can impair the protein folding activity of the bacterial chaperone system, thereby increasing bacterial susceptibility toward the defensive attack by the host.


Subject(s)
HSP70 Heat-Shock Proteins/metabolism , Heat-Shock Proteins/antagonists & inhibitors , Molecular Chaperones/antagonists & inhibitors , Nitric Oxide/pharmacology , Nitrosation/drug effects , Cell Division/drug effects , Chaperonin 60/drug effects , Escherichia coli/genetics , Escherichia coli/metabolism , Escherichia coli Proteins , HSP40 Heat-Shock Proteins , Molecular Chaperones/metabolism , Nitric Oxide/biosynthesis , Protein Folding , Sequence Deletion/genetics , Zinc/metabolism , Zinc Fingers/physiology
9.
Int Immunopharmacol ; 1(8): 1407-20, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11515808

ABSTRACT

Studies from many laboratories have demonstrated the complex role of NO in inflammatory processes. Prolonged exposure to NO shifts the cellular redox potential to a more oxidized state and this is critically regulated by intracellular levels of reduced glutathione. NO-mediated stress will alter gene expression patterns, and the number of genes known to be involved is steadily increasing. Indeed, due to its S-nitrosating activity in the presence of oxygen, NO can modify the activity of transcription factors containing zinc finger motifs or cysteines within the DNA-binding domain. In addition, we are faced with not only NO acting as a powerful inducer of apoptosis or of necrosis in some cells, but also representing an equally powerful protection from cell death in many instances. Some of these apparent discrepancies may be explained by different capacities of cells to cope with the stress of NO exposure. Here, we review our findings on the complex impact of NO on transcriptional regulation of genes, cell death and cell survival. These NO-mediated actions will contribute to a better understanding of the impact of inducible nitric oxide synthase (iNOS) enzyme activity during inflammatory reactions.


Subject(s)
Cell Death/physiology , Cell Survival/physiology , Gene Expression Regulation/physiology , Nitric Oxide Synthase/physiology , Nitric Oxide/physiology , Animals , Humans , Nitric Oxide Synthase/biosynthesis , Nitric Oxide Synthase Type II
10.
Cell Death Differ ; 8(5): 515-27, 2001 May.
Article in English | MEDLINE | ID: mdl-11423912

ABSTRACT

Reactive oxygen species (ROS) play a pivotal role in UVA-induced cell damage. As expression of the inducible nitric oxide synthase (iNOS) is a normal response of human skin to UV radiation we examined the role of nitric oxide (NO) as a protective agent during or even after UVA1- or ROS-exposure against apoptosis or necrosis of rat endothelial cells. When added during or up to 2 h subsequent to UVA1 or ROS exposure the NO-donor S-nitroso-cysteine (SNOC) at concentrations from 100-1000 microM significantly protects from both apoptosis as well as necrosis. The NO-mediated protection strongly correlates with complete inhibition of lipid peroxidation (sixfold increase of malonedialdehyde formation in untreated versus 1.2-fold with 1 mM SNOC). NO-mediated protection of membrane function was also shown by the inhibition of cytochrome c leakage in UVA1 treated cells, a process not accompanied by alterations in Bax and Bcl-2 protein levels. Thus, the experiments presented demonstrate that NO exposure during or even after a ROS-mediated toxic insult fully protects from apoptosis or necrosis by maintaining membrane integrity and function.


Subject(s)
Apoptosis/radiation effects , Nitric Oxide/metabolism , Reactive Oxygen Species/metabolism , S-Nitrosothiols , Ultraviolet Rays , Animals , Antioxidants/pharmacology , Cells, Cultured , Cysteine/analogs & derivatives , Cysteine/pharmacology , Cytochrome c Group/metabolism , Cytoprotection/drug effects , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Endothelium, Vascular/radiation effects , Gene Expression Regulation/radiation effects , Hydrogen Peroxide/metabolism , Hydrogen Peroxide/pharmacology , Lipid Peroxidation/drug effects , Lipid Peroxidation/radiation effects , Microscopy, Fluorescence , Mitochondria/drug effects , Mitochondria/metabolism , Mitochondria/radiation effects , Necrosis , Nitric Oxide/pharmacology , Nitric Oxide Donors/pharmacology , Nitroso Compounds/pharmacology , Oxygen/metabolism , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Rats, Wistar , Rose Bengal , Singlet Oxygen , bcl-2-Associated X Protein
11.
Mol Med ; 7(11): 748-54, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11788788

ABSTRACT

BACKGROUND: Nitric oxide (NO) has frequently been shown to inhibit leukocyte adherence to activated endothelium thus displaying anti-adhesive and immunosuppressive activities. A molecular mechanism contributing to this effect is described. MATERIALS AND METHODS: Primary murine aortic endothelial cells were activated with interleukin (IL)-1beta to express intercellular adhesion molecule-1 (ICAM-1) mRNA in the presence or absence of the physiological spontaneous NO-donor S-nitrosocysteine. Subsequently, semiquantitative RT-PCR and gel shift assays with nuclear extracts were performed to analyse the effects of NO on ICAM-1 mRNA expression and on the activity of transcription factors involved in ICAM-1 transcription. In addition, luciferase reporter gene activity of cytokine-activated cells transiently transfected with an ICAM-1 promoter-luciferase construct and cultured in the presence of the slow-releasing NO-donor DETA/NO was determined. RESULTS: NO at subtoxic concentrations decreases IL-1beta-induced endothelial ICAM-1 mRNA expression. This inhibition occurs at the transcriptional level, as NO affects IL-1b-induced ICAM-1 promoter activity in transiently transfected cells. Using gel-shift assays and double-stranded oligonucleotide consensus sequences of the known transcription factor binding sites of the ICAM-1 promoter, Sp1 and AP-1 were identified as transcriptional activators of IL-1beta-driven ICAM-1 expression. The DNA binding of both of these transcription factors to specific binding sites of the ICAM-1 promoter was decreased in MAEC exposed to NO. CONCLUSIONS: Our studies indicate that the anti-adhesive effect of NO concentrations equivalent to high-output NO synthesis is mediated, at least in part, by inhibition of ICAM-1 expression via a concerted action of NO on the redox-sensitive transcriptional activators Sp1 and AP-1. This molecular mechanism may contribute to the anti-inflammatory actions of NO synthesized by the inducible NO synthase.


Subject(s)
Cysteine/analogs & derivatives , Endothelium, Vascular/physiology , Intercellular Adhesion Molecule-1/biosynthesis , Interleukin-1/pharmacology , Nitric Oxide Donors/pharmacology , Nitric Oxide/physiology , Sp1 Transcription Factor/physiology , Transcription Factor AP-1/physiology , Animals , Cells, Cultured , Cysteine/pharmacology , Endothelium, Vascular/drug effects , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Humans , Intercellular Adhesion Molecule-1/genetics , Interleukin-1/physiology , Mice , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , S-Nitrosothiols/pharmacology , Transcription, Genetic
12.
Br J Pharmacol ; 131(3): 473-81, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11015297

ABSTRACT

The therapeutic use of the antifungal drug amphotericin B (AmB) is limited due to severe side effects like glomerular vasoconstriction and risk of renal failure during AmB administration. As nitric oxide (NO) has substantial functions in renal autoregulation, we have determined the effects of AmB on endothelial constitutive NO synthase (ecNOS) expression and activity in human and rat endothelial cell cultures. AmB used at concentrations of 0.6 to 1.25 microg ml(-1) led to increases in ecNOS mRNA and protein expression as well as NO production. This was the result of an increased ecNOS mRNA half-life. In contrast, incubation of cells with higher albeit subtoxic concentrations of AmB (2.5 - 5.0 microg ml(-1)) resulted in a decrease or respectively in completely abolished ecNOS mRNA and protein expression with a strongly reduced or inhibited ecNOS activity, due to a decrease of ecNOS mRNA half-life. None of the AmB concentrations affected promoter activity as found with a reporter gene construct stably transfected into ECV304 cells. Thus, our experiments show a concentration-dependent biphasic effect of AmB on expression and activity of ecNOS, an effect best explained by AmB influencing ecNOS mRNA stability. In view of the known renal accumulation of this drug the results reported here could help to elucidate its renal toxicity.


Subject(s)
Amphotericin B/pharmacology , Endothelium, Vascular/drug effects , Nitric Oxide Synthase/genetics , RNA Stability/drug effects , Animals , Anti-Bacterial Agents/pharmacology , Cells, Cultured , Cytokines/metabolism , Endothelium, Vascular/metabolism , Gene Expression Regulation, Enzymologic/drug effects , Humans , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type III , Promoter Regions, Genetic/drug effects , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Rats
13.
Nitric Oxide ; 4(6): 609-14, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11139369

ABSTRACT

Zinc is crucial for the biosynthesis, storage, and secretion of insulin in pancreatic islet cells. We have previously presented evidence that NO interferes with cellular Zn(2+) homeostasis and we therefore investigated the influence of chronic NO exposure on the labile islet cell Zn(2+) content. A strong fluorescence activity in a large islet cell subpopulation was found after staining with the Zn(2+)-specific fluorophore Zinquin. Culture for 24 h in the presence of nontoxic concentrations of the slow-releasing NO donor DETA/NO resulted in a significantly reduced Zn(2+)-dependent fluorescence. This appears to be islet specific as in endothelial cells DETA/NO exposure enhanced the Zn(2+)-dependent fluorescence activity in a concentration-dependent manner. These results suggest that NO interferes with cellular Zn(2+) homeostasis, which in islet cells is crucial for proper hormone delivery and thus special cell function.


Subject(s)
Islets of Langerhans/metabolism , Nitric Oxide/metabolism , Zinc/metabolism , Animals , Cells, Cultured , Dose-Response Relationship, Drug , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Flow Cytometry , Fluorescence , Fluorescent Dyes , Homeostasis/drug effects , Islets of Langerhans/cytology , Islets of Langerhans/drug effects , Nitric Oxide/pharmacology , Nitric Oxide Donors/pharmacology , Quinolones , Rats , Rats, Wistar , Tosyl Compounds , Triazenes/pharmacology
14.
Antioxid Redox Signal ; 2(3): 585-605, 2000.
Article in English | MEDLINE | ID: mdl-11229370

ABSTRACT

We summarize here our current knowledge about inducible nitric oxide synthase (NOS) activity in human diseases and disorders. As basic research discovers more and more effects of low or high concentrations of NO toward molecular and cellular targets, successful therapies involving inhibition of NO synthesis or application of NO to treat human diseases are still lacking. This is in part due to the fact that the impact of NO on cell function or death are complex and often even appear to be contradictory. NO may be cytotoxic but may also protect cells from a toxic insult; it is apoptosis-inducing but also exhibits prominent anti-apoptotic activity. NO is an antioxidant but may also compromise the cellular redox state via oxidation of thiols like glutathione. NO may activate specific signal transduction pathways but is also reported to inhibit exactly these, and NO may activate or inhibit gene transcription. The situation may even be more complicated, because NO, depending on its concentration, may react with oxygen or the superoxide anion radical to yield reactive species with a much broader chemical reaction spectrum than NO itself. Thus, the action of NO during inflammatory reactions has to be considered in the context of timing and duration of its synthesis as well as stages and specific events in inflammation.


Subject(s)
Inflammation/enzymology , Nitric Oxide Synthase/biosynthesis , Nitric Oxide Synthase/metabolism , Apoptosis , Humans , Models, Biological , Nitrates/metabolism , Nitric Oxide/chemistry , Nitric Oxide Synthase Type II , Oxidation-Reduction , Oxidative Stress , Signal Transduction , Transcription, Genetic
15.
Free Radic Biol Med ; 27(7-8): 773-80, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10515581

ABSTRACT

Different cell types exhibit huge differences towards the cytotoxic action of NO. In search for an explanation, we used subtoxic concentrations of the NO-donors S-nitrosocysteine (SNOC) for short-term challenge and of (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1- ium-1,2-diolate (DETA/NO) for longer periods of exposure, respectively, and subtoxic concentrations of the oxidant H2O2 to determine the impact on intracellular reduced glutathione (GSH) concentrations. We find that GSH concentrations are always decreased, but that different cell types show different responses. Incubation of the relatively NO-sensitive murine lymphocytes with both NO-donors, but not with H2O2, resulted in a nearly complete loss of intracellular GSH. Short-term NO-treatment of P815 mastocytoma cells, also sensitive to NO-mediated cell death, decreased GSH to a similar extent only if either glutathione reductase (GSHR) activity or y-glutamylcysteine synthetase (gammaGCS) activity were inhibited concomitantly by specific inhibitors. Long-term NO-treatment of P815 cells, however, resulted in a significant decrease of GSH that could be further enhanced by inhibiting gammaGCS activity. In contrast, neither short-term nor long-term NO-exposure nor H2O2-treatment affected intracellular GSH levels of L929 fibroblasts, which were previously shown to be extremely resistant towards NO, whereas concomitant gammaGCS inhibition, but not GSHR inhibition, completely decreased GSH concentrations. These results show that different cell types use different pathways trying to maintain glutathione concentrations to cope with nitrosative stress, and the overall capability to maintain a critical amount of GSH correlates with susceptibility to NO-induced cell death.


Subject(s)
Glutathione/metabolism , Nitric Oxide/pharmacology , Oxidative Stress , S-Nitrosothiols , Animals , Cell Line , Cysteine/analogs & derivatives , Cysteine/pharmacology , Enzyme Inhibitors/pharmacology , Flow Cytometry , Glutamate-Cysteine Ligase/antagonists & inhibitors , Glutathione Reductase/antagonists & inhibitors , Hydrogen Peroxide/pharmacology , Mice , Nitroso Compounds/pharmacology , Pyrazoles/chemistry , Triazenes/pharmacology
17.
Diabetologia ; 42(4): 457-64, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10230650

ABSTRACT

AIMS/HYPOTHESIS: Type I (insulin-dependent) diabetes mellitus is characterised by leucocyte infiltration of pancreatic islets and a progressive destruction of insulin-producing beta cells. As endothelial nitric oxide production is known to regulate adhesion molecule expression and leucocyte permeation, we examined the activity and expression of the constitutive nitric oxide synthase (ecNOS) of islet endothelial cells from prediabetic BBdp rats. METHODS: Cultures of aortic endothelial cells and islet capillary endothelial cells were established from young normoglycaemic BBdp rats, Wistar rats and diabetes-resistant BBdr rats, all matched for age. Nitrite and citrulline production was measured in all culture supernatants as indicators for ecNOS activities. Expression of ecNOS mRNA was assessed by reverse transcription-polymerase chain reaction. RESULTS: In contrast to those of the aorta, the Wistar rat islet derived endothelial cells exhibited a strong positive correlation of ecNOS activity with the culture medium glucose concentration but none of the BB rat-derived islet endothelial cells showed a similar glucose-responsiveness. Furthermore, at physiological as well as at increased glucose concentrations islet endothelia from all BBdp rats exhibited a considerable decrease in ecNOS activity by a factor of 3 to 6, indicating a specific dysfunction which is also found for the inducible nitric oxide synthase activity after cytokine challenge but effects were less (2.5 to 3 times) dramatic. In contrast, aorta endothelia from all rats exhibited identical ecNOS activities and no glucose responsiveness. We also found a correlation between ecNOS activities and ecNOS-mRNA expression and can exclude the involvement of the inducible isoform. CONCLUSION/INTERPRETATION: A reproducible and highly significant dysfunction of islet ecNOS expression and activity in young normoglycaemic BBdp rats, which strongly correlates with the probability for disease manifestation is shown.


Subject(s)
Diabetes Mellitus, Type 1/enzymology , Endothelium, Vascular/enzymology , Islets of Langerhans/enzymology , Nitric Oxide Synthase/metabolism , Animals , Blood Glucose/metabolism , Cells, Cultured , Islets of Langerhans/blood supply , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase Type II , Nitric Oxide Synthase Type III , RNA, Messenger/metabolism , Rats , Rats, Wistar
18.
J Biol Chem ; 274(10): 6130-7, 1999 Mar 05.
Article in English | MEDLINE | ID: mdl-10037696

ABSTRACT

A variety of toxic and modulating events induced by UVA exposure are described to cause cell death via apoptosis. Recently, we found that UV irradiation of human skin leads to inducible nitric-oxide synthase (iNOS) expression in keratinocytes and endothelial cells (ECs). We have now searched for the role of iNOS expression and nitric oxide (NO) synthesis in UVA-induced apoptosis as detected by DNA-specific fluorochrome labeling and in DNA fragmentation visualized by in situ nick translation in ECs. Activation with proinflammatory cytokines 24 h before UVA exposure leading to iNOS expression and endogenous NO synthesis fully protects ECs from the onset of apoptosis. This protection was completely abolished in the presence of the iNOS inhibitor L-N5-(1-iminoethyl)-ornithine (0.25 mM). Additionally, preincubation of cells with the NO donor (Z)-1-[N(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-i um-1, 2-diolate at concentrations from 10 to 1000 microM as an exogenous NO-generating source before UVA irradiation led to a dose-dependent inhibition of both DNA strand breaks and apoptosis. In search of the molecular mechanism responsible for the protective effect, we find that protection from UVA-induced apoptosis is tightly correlated with NO-mediated increases in Bcl-2 expression and a concomitant inhibition of UVA-induced overexpression of Bax protein. In conclusion, we present evidence for a protective role of iNOS-derived NO in skin biology, because NO either endogenously produced or exogenously applied fully protects against UVA-induced cell damage and death. We also show that the NO-mediated expression modulation of proteins of the Bcl-2 family, an event upstream of caspase activation, appears to be the molecular mechanism underlying this protection.


Subject(s)
Apoptosis/genetics , Endothelium, Vascular/pathology , Nitric Oxide/biosynthesis , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Animals , Apoptosis/drug effects , Apoptosis/radiation effects , Cells, Cultured , Endothelium, Vascular/metabolism , Endothelium, Vascular/radiation effects , Humans , Male , Nitric Oxide Donors/metabolism , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Rats , Rats, Wistar , Skin/metabolism , Skin/pathology , Skin/radiation effects , Ultraviolet Rays , Up-Regulation
20.
Int J Angiol ; 8(5): 21-24, 1999.
Article in English | MEDLINE | ID: mdl-10191369

ABSTRACT

This study was done to determine the effects of the angioprotective agent dobesilate on expression and activity on the constitutive nitric oxide synthase (ecNOS) in resident endothelial cells, as well as of the inducible nitric oxide synthase (iNOS) in cytokine-activated endothelial cells, by recording, in culture supernatants, the concentrations of citrulline as a reaction product of both enzymes. In capillary, microvascular, and macrovascular endothelial cells, Mg dobesilate incubation (0.25-1 mM) for 24 hours led to a highly significant concentration-correlating increase in ecNOS activities. These increases were not due to iNOS expression, and with cytokine-activated endothelial cell cultures that do express iNOS only moderate effects with little or no concentration dependency were seen. Addition of the NOS inhibitor NG-monomethyl-L-arginine (NMA) significantly suppresses citrulline formation in all cultures as evidence for the enzyme specificity.

SELECTION OF CITATIONS
SEARCH DETAIL
...